These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3229005)

  • 21. Characterization of a Ca2+-calmodulin-stimulated cyclic GMP phosphodiesterase from bovine brain.
    Shenolikar S; Thompson WJ; Strada SJ
    Biochemistry; 1985 Jan; 24(3):672-8. PubMed ID: 2986683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by new anthraquinone compounds, K-259-2 and KS-619-1, of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Matsuda Y; Nakanishi S; Nagasawa K; Kase H
    Biochem Pharmacol; 1990 Mar; 39(5):841-9. PubMed ID: 2155616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity.
    Tokarska-Schlattner M; Wallimann T; Schlattner U
    Mol Pharmacol; 2002 Mar; 61(3):516-23. PubMed ID: 11854431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents.
    Weishaar RE; Burrows SD; Kobylarz DC; Quade MM; Evans DB
    Biochem Pharmacol; 1986 Mar; 35(5):787-800. PubMed ID: 3006691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic administration of doxorubicin on myocardial alpha-adrenergic receptors, histamine, cyclic nucleotides, calcium, norepinephrine, calmodulin, and guanylate cyclase activity, and plasma catecholamines in rats.
    Robison TW; Giri SN
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 54(3):182-9. PubMed ID: 2894092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes.
    Sharma RK; Kalra J
    Biochemistry; 1993 May; 32(19):4975-8. PubMed ID: 8388250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
    Sharma RK; Wang JH; Wu Z
    J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Bode DC; Kanter JR; Brunton LL
    Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.
    Lam HY
    Biochem Biophys Res Commun; 1984 Jan; 118(1):27-32. PubMed ID: 6320825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
    Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
    J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cyclic nucleotide phosphodiesterase and calcineurin by spermine, a calcium-independent calmodulin antagonist.
    Walters JD; Johnson JD
    Biochim Biophys Acta; 1988 Nov; 957(1):138-42. PubMed ID: 2846068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adriamycin, aclacinomycin and thepirubicin intracardiac distribution examined by fluorescence microscopy.
    Scalori V; Alessandrì MG; Giovannini L; Bertelli AA; Mian M
    Chemioterapia; 1988 Jun; 7(3):179-83. PubMed ID: 3168073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis.
    Dartsch DC; Schaefer A; Boldt S; Kolch W; Marquardt H
    Apoptosis; 2002 Dec; 7(6):537-48. PubMed ID: 12370496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of two calcium/calmodulin-dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography.
    Hansen RS; Beavo JA
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2788-92. PubMed ID: 6283544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone is a potent calmodulin antagonist.
    Nokin P; Blondiaux JP; Schaeffer P; Jungbluth L; Lugnier C
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):367-73. PubMed ID: 2544810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of alpha adrenergic antagonists with calmodulin.
    Earl CQ; Prozialeck WC; Weiss B
    Life Sci; 1984 Jul; 35(5):525-34. PubMed ID: 6146911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.